Trauma-registry survival outcome follow up: 30 days is mandatory and appears sufficient.

Injury
Tuomas BrinckTim Söderlund

Abstract

Thirty-day in-hospital mortality is a common outcome measure in trauma-registry research and benchmarking. However, this does not include deaths after hospital discharge before 30 days or late deaths beyond 30 days since the injury. To evaluate the reliability of this outcome measure, we assessed the timing and causes of death during the first year after major blunt trauma in patients treated at a single tertiary trauma center. We used the Helsinki Trauma Registry to identify severely injured (NISS ≥ 16) blunt trauma patients during 2006 to 2015. The Population Register center of Finland provided the mortality data for patients and Statistics Finland provided the cause of death information from death certificates. Disease, work-related disease, medical treatment, and unknown cause of death were considered as non-trauma related deaths. We divided the 1-year study period into the following three categories: in-hospital death before 30 days (Group 1), death after discharge but within 30 days (Group 2), and death 31 to 365 days since admission (Group 3). We included 3557 patients with a median NISS of 29. Altogether, 21.8% (776/3557) patients died during the first year since the injury. Of these non-survivors, 12.7% (450) were in G...Continue Reading

References

May 16, 1998·Journal of the American College of Surgeons·J A AcostaD B Hoyt
Jun 12, 1998·JAMA : the Journal of the American Medical Association·R J MullinsG J Jurkovich
Oct 30, 2008·Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine·Kjetil G RingdalUNKNOWN Utstein TCD expert panel
Apr 28, 2010·Journal of the American College of Surgeons·Jeffrey A ClaridgeMark A Malangoni
Sep 14, 2010·Journal of the American Geriatrics Society·Ross J FleischmanCraig D Newgard
Mar 10, 2011·JAMA : the Journal of the American Medical Association·Giana H DavidsonSaman Arbabi
Mar 15, 2014·Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine·Poya GhorbaniLovisa Strömmer
Nov 18, 2014·Journal of Emergencies, Trauma, and Shock·Luke HansenMarie Crandall
Jun 4, 2015·European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society·T BrinckR Lefering
Oct 24, 2015·Emergency Medicine Journal : EMJ·Omar BouamraFiona Lecky
Oct 24, 2015·The Journal of Surgical Research·Carrie ValdezLakhmir S Chawla
Feb 1, 2012·European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society·R LeferingF Lecky
May 26, 2017·Scandinavian Journal of Surgery : SJS : Official Organ for the Finnish Surgical Society and the Scandinavian Surgical Society·M HeinänenT Söderlund
Mar 10, 2018·The Journal of Trauma and Acute Care Surgery·James M BardesDemetrios Demetriades
Sep 19, 2018·European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society·Mikko HeinänenTim Söderlund
Feb 13, 2019·European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society·Bismil Ali AliTomas Belzunegui Otano
Mar 9, 2019·European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society·Sten SaarPeep Talving
Nov 7, 2019·Scandinavian Journal of Surgery : SJS : Official Organ for the Finnish Surgical Society and the Scandinavian Surgical Society·M HeinänenT Söderlund

❮ Previous
Next ❯

Citations

Apr 4, 2021·International Journal of Environmental Research and Public Health·Ching-Yi ShenTse-Hao Chen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.